| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Long Noncoding | 6 | 2025 | 246 | 2.100 |
Why?
|
| Hepatoblastoma | 7 | 2024 | 184 | 1.930 |
Why?
|
| Liver Neoplasms | 9 | 2024 | 1410 | 1.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2025 | 2122 | 1.120 |
Why?
|
| MicroRNAs | 11 | 2025 | 951 | 1.010 |
Why?
|
| Gene Expression Profiling | 13 | 2023 | 1911 | 0.920 |
Why?
|
| Computational Biology | 9 | 2024 | 887 | 0.730 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2023 | 999 | 0.690 |
Why?
|
| Transcriptome | 3 | 2023 | 1126 | 0.640 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2022 | 961 | 0.540 |
Why?
|
| Gene Regulatory Networks | 6 | 2018 | 397 | 0.530 |
Why?
|
| Neoplasms | 6 | 2024 | 3025 | 0.520 |
Why?
|
| RNA, Messenger | 8 | 2025 | 2902 | 0.500 |
Why?
|
| Neuroblastoma | 4 | 2022 | 539 | 0.500 |
Why?
|
| Receptor, Notch1 | 2 | 2015 | 79 | 0.480 |
Why?
|
| Glioblastoma | 3 | 2018 | 375 | 0.470 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2015 | 63 | 0.470 |
Why?
|
| Cell Line, Tumor | 18 | 2025 | 3751 | 0.460 |
Why?
|
| Negative-Pressure Wound Therapy | 2 | 2025 | 19 | 0.460 |
Why?
|
| Algorithms | 11 | 2015 | 1732 | 0.450 |
Why?
|
| Transcription Factors | 10 | 2019 | 2703 | 0.430 |
Why?
|
| Homeodomain Proteins | 2 | 2015 | 584 | 0.390 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2024 | 569 | 0.380 |
Why?
|
| Promoter Regions, Genetic | 10 | 2021 | 1413 | 0.370 |
Why?
|
| Humans | 65 | 2025 | 133849 | 0.370 |
Why?
|
| Sequence Analysis, RNA | 5 | 2023 | 429 | 0.370 |
Why?
|
| Sequence Alignment | 3 | 2015 | 633 | 0.360 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 349 | 0.340 |
Why?
|
| Radiation Tolerance | 3 | 2025 | 67 | 0.310 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 2023 | 96 | 0.310 |
Why?
|
| Cytokines | 2 | 2025 | 1396 | 0.310 |
Why?
|
| Oncogenes | 3 | 2018 | 179 | 0.300 |
Why?
|
| Cell Line | 8 | 2021 | 2837 | 0.300 |
Why?
|
| Cell Differentiation | 4 | 2025 | 2026 | 0.290 |
Why?
|
| Animals | 33 | 2025 | 36363 | 0.290 |
Why?
|
| Mice | 24 | 2025 | 18883 | 0.280 |
Why?
|
| Sequence Analysis, DNA | 6 | 2022 | 1833 | 0.280 |
Why?
|
| Sequence Analysis, Protein | 2 | 2004 | 49 | 0.280 |
Why?
|
| Binding Sites | 7 | 2014 | 1369 | 0.270 |
Why?
|
| Mutation | 8 | 2023 | 6289 | 0.270 |
Why?
|
| T-Lymphocytes | 6 | 2024 | 1814 | 0.260 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2018 | 197 | 0.250 |
Why?
|
| Ribonuclease III | 2 | 2025 | 103 | 0.250 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2025 | 147 | 0.240 |
Why?
|
| RNA, Neoplasm | 2 | 2018 | 144 | 0.240 |
Why?
|
| Acrylamides | 1 | 2025 | 25 | 0.240 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2025 | 20 | 0.240 |
Why?
|
| Genome, Human | 3 | 2021 | 1350 | 0.240 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2015 | 1070 | 0.230 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2025 | 1006 | 0.230 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2021 | 616 | 0.230 |
Why?
|
| N-Myc Proto-Oncogene Protein | 2 | 2022 | 66 | 0.230 |
Why?
|
| Urinary Catheterization | 1 | 2024 | 57 | 0.230 |
Why?
|
| Glypicans | 1 | 2024 | 41 | 0.230 |
Why?
|
| Receptors, Ghrelin | 1 | 2024 | 28 | 0.220 |
Why?
|
| Wound Healing | 2 | 2025 | 496 | 0.220 |
Why?
|
| Interleukin-15 | 1 | 2024 | 96 | 0.220 |
Why?
|
| Separase | 2 | 2014 | 29 | 0.220 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2025 | 151 | 0.220 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2025 | 92 | 0.220 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2015 | 248 | 0.210 |
Why?
|
| Germinal Center | 4 | 2013 | 38 | 0.210 |
Why?
|
| Immunophenotyping | 1 | 2024 | 342 | 0.210 |
Why?
|
| RNA, Untranslated | 2 | 2021 | 120 | 0.210 |
Why?
|
| Cell Survival | 6 | 2025 | 891 | 0.210 |
Why?
|
| Catheter-Related Infections | 1 | 2024 | 104 | 0.210 |
Why?
|
| Piperidines | 1 | 2025 | 239 | 0.210 |
Why?
|
| Rats, Wistar | 1 | 2024 | 400 | 0.200 |
Why?
|
| DNA-Binding Proteins | 4 | 2019 | 2161 | 0.200 |
Why?
|
| Protons | 2 | 2021 | 98 | 0.200 |
Why?
|
| Diet, High-Fat | 1 | 2024 | 231 | 0.200 |
Why?
|
| Sex Characteristics | 1 | 2024 | 335 | 0.190 |
Why?
|
| Signal Transduction | 7 | 2025 | 4896 | 0.190 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2022 | 78 | 0.190 |
Why?
|
| Disease Models, Animal | 9 | 2025 | 4772 | 0.190 |
Why?
|
| Chromatin Assembly Factor-1 | 1 | 2021 | 9 | 0.190 |
Why?
|
| Prognosis | 7 | 2024 | 5070 | 0.190 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2021 | 18 | 0.180 |
Why?
|
| RNA Interference | 2 | 2014 | 544 | 0.180 |
Why?
|
| Urinary Tract Infections | 1 | 2024 | 243 | 0.180 |
Why?
|
| RNA, Small Interfering | 1 | 2023 | 714 | 0.180 |
Why?
|
| Oxadiazoles | 1 | 2021 | 25 | 0.180 |
Why?
|
| Consensus Sequence | 2 | 2015 | 57 | 0.180 |
Why?
|
| Cell Death | 2 | 2019 | 251 | 0.180 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2024 | 884 | 0.170 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 298 | 0.170 |
Why?
|
| B-Lymphocytes | 4 | 2013 | 550 | 0.170 |
Why?
|
| Clonal Evolution | 1 | 2020 | 49 | 0.170 |
Why?
|
| Amish | 1 | 2020 | 11 | 0.170 |
Why?
|
| Atovaquone | 1 | 2019 | 10 | 0.170 |
Why?
|
| Neoplasm Transplantation | 2 | 2017 | 399 | 0.160 |
Why?
|
| Linear Energy Transfer | 1 | 2019 | 9 | 0.160 |
Why?
|
| Fatty Acids | 1 | 2022 | 370 | 0.160 |
Why?
|
| Compulsive Behavior | 1 | 2019 | 41 | 0.160 |
Why?
|
| Base Sequence | 5 | 2018 | 3171 | 0.160 |
Why?
|
| DNA End-Joining Repair | 1 | 2019 | 38 | 0.160 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 1789 | 0.160 |
Why?
|
| Genes, BRCA1 | 1 | 2019 | 61 | 0.160 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 124 | 0.160 |
Why?
|
| Photons | 1 | 2019 | 53 | 0.160 |
Why?
|
| Homologous Recombination | 1 | 2019 | 100 | 0.160 |
Why?
|
| Chromosome Aberrations | 1 | 2022 | 626 | 0.160 |
Why?
|
| Vaccination | 1 | 2024 | 1011 | 0.160 |
Why?
|
| AIDS Dementia Complex | 1 | 2019 | 22 | 0.150 |
Why?
|
| Piperazines | 1 | 2021 | 257 | 0.150 |
Why?
|
| Down Syndrome | 1 | 2022 | 230 | 0.150 |
Why?
|
| Methamphetamine | 1 | 2019 | 48 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2023 | 501 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2025 | 734 | 0.150 |
Why?
|
| Central Nervous System Stimulants | 1 | 2019 | 131 | 0.150 |
Why?
|
| Fetal Hemoglobin | 1 | 2018 | 28 | 0.150 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2018 | 29 | 0.150 |
Why?
|
| Erythroid Cells | 1 | 2018 | 24 | 0.150 |
Why?
|
| HIV Infections | 2 | 2022 | 2066 | 0.150 |
Why?
|
| Encephalitis | 1 | 2019 | 121 | 0.150 |
Why?
|
| Carcinogenesis | 1 | 2021 | 363 | 0.150 |
Why?
|
| Receptor, EphA2 | 1 | 2018 | 29 | 0.150 |
Why?
|
| Interleukin-13 Receptor alpha2 Subunit | 1 | 2018 | 20 | 0.140 |
Why?
|
| Antigenic Variation | 1 | 2018 | 42 | 0.140 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2017 | 60 | 0.140 |
Why?
|
| Genital Neoplasms, Female | 1 | 2018 | 47 | 0.140 |
Why?
|
| Child | 7 | 2024 | 25712 | 0.140 |
Why?
|
| Male | 21 | 2025 | 65815 | 0.140 |
Why?
|
| Cognitive Dysfunction | 1 | 2022 | 311 | 0.140 |
Why?
|
| Atazanavir Sulfate | 1 | 2017 | 6 | 0.140 |
Why?
|
| Epigenesis, Genetic | 2 | 2019 | 773 | 0.140 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 225 | 0.130 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 377 | 0.130 |
Why?
|
| Microbiota | 1 | 2022 | 442 | 0.130 |
Why?
|
| Liver | 8 | 2021 | 1867 | 0.130 |
Why?
|
| Tyrosinemias | 1 | 2016 | 7 | 0.130 |
Why?
|
| Health Status Disparities | 1 | 2019 | 246 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 697 | 0.130 |
Why?
|
| Rats, Transgenic | 3 | 2022 | 15 | 0.130 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2017 | 142 | 0.130 |
Why?
|
| Metformin | 1 | 2018 | 162 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 263 | 0.130 |
Why?
|
| DNA Copy Number Variations | 2 | 2020 | 1022 | 0.130 |
Why?
|
| Quinazolines | 1 | 2017 | 184 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 792 | 0.130 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 2656 | 0.130 |
Why?
|
| Up-Regulation | 2 | 2021 | 905 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2019 | 423 | 0.120 |
Why?
|
| Genomics | 3 | 2018 | 1676 | 0.120 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2015 | 21 | 0.120 |
Why?
|
| Models, Biological | 3 | 2018 | 1533 | 0.120 |
Why?
|
| Genetic Variation | 1 | 2003 | 1621 | 0.120 |
Why?
|
| Nanog Homeobox Protein | 1 | 2015 | 32 | 0.120 |
Why?
|
| Female | 19 | 2024 | 71584 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 619 | 0.120 |
Why?
|
| HIV-1 | 1 | 2019 | 488 | 0.120 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 809 | 0.110 |
Why?
|
| Epistasis, Genetic | 1 | 2014 | 103 | 0.110 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 77 | 0.110 |
Why?
|
| Receptor, ErbB-2 | 1 | 2018 | 559 | 0.110 |
Why?
|
| Apoptosis | 5 | 2021 | 1931 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2024 | 1314 | 0.110 |
Why?
|
| Gene Editing | 1 | 2016 | 212 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 609 | 0.110 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 292 | 0.110 |
Why?
|
| Young Adult | 3 | 2024 | 9885 | 0.110 |
Why?
|
| Epithelium | 1 | 2014 | 370 | 0.100 |
Why?
|
| Hippocampus | 1 | 2019 | 862 | 0.100 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 2 | 2024 | 75 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2014 | 183 | 0.100 |
Why?
|
| Rats | 4 | 2024 | 3879 | 0.100 |
Why?
|
| RNA, Transfer | 1 | 2013 | 76 | 0.100 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 1717 | 0.100 |
Why?
|
| Software | 2 | 2009 | 737 | 0.100 |
Why?
|
| Obesity | 1 | 2024 | 2410 | 0.100 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2013 | 246 | 0.100 |
Why?
|
| Caveolin 1 | 1 | 2012 | 50 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 873 | 0.090 |
Why?
|
| Child, Preschool | 7 | 2024 | 14776 | 0.090 |
Why?
|
| Genetic Therapy | 1 | 2016 | 733 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2014 | 688 | 0.090 |
Why?
|
| Cell Proliferation | 5 | 2019 | 2539 | 0.090 |
Why?
|
| Amino Acid Motifs | 3 | 2010 | 202 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 463 | 0.090 |
Why?
|
| Lymphoma, B-Cell | 1 | 2013 | 150 | 0.090 |
Why?
|
| Neurons | 1 | 2021 | 2034 | 0.090 |
Why?
|
| Mammary Glands, Animal | 1 | 2014 | 477 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2010 | 7 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2015 | 869 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2025 | 248 | 0.090 |
Why?
|
| Genes, Regulator | 1 | 2010 | 57 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 717 | 0.080 |
Why?
|
| Protein Domains | 2 | 2023 | 251 | 0.080 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 1489 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2011 | 262 | 0.080 |
Why?
|
| Systems Biology | 1 | 2010 | 63 | 0.080 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2009 | 5 | 0.080 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2009 | 23 | 0.080 |
Why?
|
| DNA | 1 | 2015 | 1675 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 1046 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 395 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2024 | 5173 | 0.070 |
Why?
|
| Transcription, Genetic | 3 | 2010 | 1757 | 0.070 |
Why?
|
| Hep G2 Cells | 2 | 2018 | 97 | 0.070 |
Why?
|
| Databases, Genetic | 3 | 2018 | 501 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 4800 | 0.070 |
Why?
|
| Data Collection | 1 | 2009 | 397 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 381 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 2763 | 0.070 |
Why?
|
| Pancreas | 2 | 2025 | 233 | 0.070 |
Why?
|
| Infant | 5 | 2024 | 13135 | 0.070 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2009 | 149 | 0.070 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 318 | 0.070 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 467 | 0.070 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2007 | 33 | 0.070 |
Why?
|
| Gene Expression | 3 | 2019 | 1614 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2019 | 1102 | 0.070 |
Why?
|
| Mice, Inbred Strains | 2 | 2017 | 321 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2018 | 613 | 0.060 |
Why?
|
| Heterografts | 2 | 2017 | 199 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2013 | 1070 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 1760 | 0.060 |
Why?
|
| Recurrence | 2 | 2023 | 1467 | 0.060 |
Why?
|
| Vertebrates | 1 | 2005 | 40 | 0.060 |
Why?
|
| Gene Silencing | 2 | 2019 | 248 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2019 | 3969 | 0.060 |
Why?
|
| Protein Binding | 4 | 2010 | 1834 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 1409 | 0.060 |
Why?
|
| Ghrelin | 1 | 2024 | 53 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 1623 | 0.050 |
Why?
|
| Exons | 3 | 2016 | 832 | 0.050 |
Why?
|
| Thermogenesis | 1 | 2024 | 48 | 0.050 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 78 | 0.050 |
Why?
|
| Hydroxamic Acids | 1 | 2024 | 65 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2004 | 298 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2018 | 3167 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2024 | 92 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2020 | 838 | 0.050 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2024 | 175 | 0.050 |
Why?
|
| Vincristine | 1 | 2024 | 196 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2013 | 3050 | 0.050 |
Why?
|
| Pedigree | 2 | 2020 | 1694 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2015 | 317 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2024 | 453 | 0.050 |
Why?
|
| Oxycodone | 1 | 2022 | 12 | 0.050 |
Why?
|
| Antigens, CD19 | 1 | 2023 | 181 | 0.050 |
Why?
|
| Receptors, Cytokine | 1 | 2022 | 69 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2024 | 836 | 0.050 |
Why?
|
| Eating | 1 | 2024 | 387 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2003 | 240 | 0.050 |
Why?
|
| Relative Biological Effectiveness | 1 | 2021 | 8 | 0.050 |
Why?
|
| ARNTL Transcription Factors | 1 | 2021 | 41 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2018 | 783 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2014 | 438 | 0.050 |
Why?
|
| Lipogenesis | 1 | 2021 | 58 | 0.040 |
Why?
|
| Machine Learning | 1 | 2024 | 330 | 0.040 |
Why?
|
| Species Specificity | 2 | 2013 | 571 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2003 | 778 | 0.040 |
Why?
|
| Middle Aged | 4 | 2024 | 29371 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 404 | 0.040 |
Why?
|
| Benzamides | 1 | 2021 | 125 | 0.040 |
Why?
|
| Carbon | 1 | 2021 | 99 | 0.040 |
Why?
|
| HIV | 1 | 2022 | 195 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2022 | 334 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2003 | 537 | 0.040 |
Why?
|
| Estrogen Receptor alpha | 2 | 2014 | 474 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2022 | 233 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 823 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 1326 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2019 | 35 | 0.040 |
Why?
|
| Phylogeny | 1 | 2022 | 784 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 2 | 2009 | 18 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2022 | 352 | 0.040 |
Why?
|
| Rad51 Recombinase | 1 | 2019 | 32 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 777 | 0.040 |
Why?
|
| Aged | 4 | 2024 | 21717 | 0.040 |
Why?
|
| Gene Drive Technology | 1 | 2019 | 6 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 1850 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2022 | 406 | 0.040 |
Why?
|
| Genetics, Population | 1 | 2020 | 198 | 0.040 |
Why?
|
| gamma-Globins | 1 | 2018 | 3 | 0.040 |
Why?
|
| Zebrafish | 1 | 2021 | 417 | 0.040 |
Why?
|
| SEER Program | 1 | 2019 | 224 | 0.040 |
Why?
|
| Methylation | 1 | 2019 | 231 | 0.040 |
Why?
|
| K562 Cells | 1 | 2018 | 100 | 0.040 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 142 | 0.040 |
Why?
|
| RNA Precursors | 1 | 2018 | 65 | 0.040 |
Why?
|
| Cell Cycle | 2 | 2014 | 627 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 336 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 327 | 0.040 |
Why?
|
| Adenosine | 1 | 2019 | 139 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2018 | 198 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 1334 | 0.040 |
Why?
|
| Cytochromes | 1 | 2017 | 7 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 152 | 0.030 |
Why?
|
| Adult | 4 | 2024 | 31925 | 0.030 |
Why?
|
| Heterozygote | 1 | 2020 | 718 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2019 | 218 | 0.030 |
Why?
|
| Chimera | 1 | 2017 | 88 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2018 | 296 | 0.030 |
Why?
|
| HIV Protease Inhibitors | 1 | 2017 | 49 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2019 | 250 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 458 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2018 | 177 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2018 | 444 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 3970 | 0.030 |
Why?
|
| Nitrobenzoates | 1 | 2016 | 7 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 232 | 0.030 |
Why?
|
| Cyclohexanones | 1 | 2016 | 19 | 0.030 |
Why?
|
| United States | 2 | 2024 | 11682 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 1304 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 267 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2019 | 562 | 0.030 |
Why?
|
| Hydrolases | 1 | 2016 | 61 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2016 | 103 | 0.030 |
Why?
|
| Inflammation | 1 | 2024 | 1595 | 0.030 |
Why?
|
| Tandem Repeat Sequences | 1 | 2015 | 38 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 1596 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2024 | 17456 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 1306 | 0.030 |
Why?
|
| Histones | 1 | 2019 | 568 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2024 | 3691 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2016 | 242 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2018 | 1136 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 896 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 823 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 1 | 2018 | 341 | 0.030 |
Why?
|
| Weaning | 1 | 2014 | 51 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 182 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 563 | 0.030 |
Why?
|
| Gene Duplication | 1 | 2015 | 371 | 0.030 |
Why?
|
| Adolescent | 2 | 2024 | 20517 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 138 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2014 | 95 | 0.030 |
Why?
|
| Decision Trees | 1 | 2013 | 52 | 0.030 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2013 | 107 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2003 | 2935 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 139 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 607 | 0.030 |
Why?
|
| Replication Protein A | 1 | 2013 | 10 | 0.030 |
Why?
|
| Aneuploidy | 1 | 2013 | 145 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 433 | 0.030 |
Why?
|
| Argonaute Proteins | 1 | 2013 | 31 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2013 | 90 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 791 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 577 | 0.020 |
Why?
|
| Incidence | 1 | 2019 | 3393 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 1134 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2012 | 199 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2018 | 1145 | 0.020 |
Why?
|
| Genotype | 1 | 2017 | 2807 | 0.020 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2010 | 9 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 717 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2010 | 72 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 813 | 0.020 |
Why?
|
| DNA Probes | 1 | 2009 | 125 | 0.020 |
Why?
|
| Mitosis | 1 | 2010 | 194 | 0.020 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2009 | 19 | 0.020 |
Why?
|
| DNA Damage | 1 | 2013 | 546 | 0.020 |
Why?
|
| Haplorhini | 1 | 2009 | 122 | 0.020 |
Why?
|
| Palatine Tonsil | 1 | 2009 | 37 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5505 | 0.020 |
Why?
|
| Transcription Factor HES-1 | 1 | 2008 | 20 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2010 | 217 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 6584 | 0.020 |
Why?
|
| Skin | 1 | 2012 | 551 | 0.020 |
Why?
|
| Survival Rate | 1 | 2014 | 2207 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 3422 | 0.020 |
Why?
|
| DNA Replication | 1 | 2010 | 363 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3638 | 0.020 |
Why?
|
| Dogs | 1 | 2009 | 800 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 2527 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 2785 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2023 | 13011 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2008 | 217 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 724 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2009 | 362 | 0.020 |
Why?
|
| Systems Integration | 1 | 2007 | 28 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3476 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 4532 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 406 | 0.020 |
Why?
|
| Aging | 1 | 2013 | 1304 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 454 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 711 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2006 | 400 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2005 | 122 | 0.010 |
Why?
|
| Protein Array Analysis | 1 | 2005 | 107 | 0.010 |
Why?
|
| Testis | 1 | 2007 | 426 | 0.010 |
Why?
|
| Lung | 1 | 2012 | 1557 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 2004 | 33 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2007 | 506 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 505 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 1872 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2005 | 789 | 0.010 |
Why?
|
| Myocardium | 1 | 2007 | 1046 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2004 | 482 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 1052 | 0.010 |
Why?
|